Scholars Central

Research articlePublished 30 Aug 2022

Omitted Liver Disease Screening in Acute Coronary Syndrome (ACS) Hides Prevalence of High Levels of Severe Liver Fibrosis

Authors: Saliu D, Veys S, Reynolds RC, Mandour O Mandour, Oben JA

1Guy's and St Thomas'NHS Foundation Trust London, Department of Gastroenterology and Hepatology, UK; 2University College London, Institute for Institute for Liver and Digestive Health, United Kingdom

Journal of Obesity & Weight Loss Therapy

Volume 12 · Issue 8 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background and Aims: Non-alcoholic fatty liver disease (NAFLD) has important associations with the metabolic syndrome and shares features with cardiovascular diseases, such as acute coronary syndrome (ACS). It is not standard of care to screen ACS patients for liver disease. We sought, to determine what proportion of patients presenting with ACS had full liver functions tests (LFTs) performed, and using available LFTs assessed for liver fibrosis. Methods: Retrospective study of patients admitted with ACS to St Thomas’ teaching hospital between 01/09/17 and 31/08/18. We determined if full LFTs had been measured to allow calculation of a fibrosis score. As a secondary outcome we audited metabolic parameters for each patient. This study was exempt from IRB review. Results: 360/521 patients (69%) met inclusion criteria of having an acute admission due to ACS: 272 males and 88 females, aged 34-91. 181(50%) had an ST elevation Myocardial infarction (STEMI), 176(49%) had a Non-ST elevation Myocardial Infarction (NSTEMI), and 3 had an unspecified ACS. 30 (8.3%) had sufficient tests performed to calculate FIB-4; 263(72%) had basic LFTs performed, and 67(19%) had no LFTs measured. Of the 30 with sufficient tests, 47% had a FIB-4 score >3.25, indicating advanced liver fibrosis (bridging fibrosis or cirrhosis). Only 2 had pre-existing known liver disease including NAFLD. Conclusion: Few patients presenting with ACS are assessed for liver fibrosis. A change in standard of care to performing a full liver screen on patients admitted with ACS would allow for the increased diagnosis of liver fibrosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Obesity & Weight Loss Therapy
  • SubjectObesity & Weight Management
  • BylineArticles whose byline prints “Saliu D”
  • BylineArticles whose byline prints “Veys S”
  • BylineArticles whose byline prints “Reynolds RC”
  • BylineArticles whose byline prints “Mandour O Mandour”
  • BylineArticles whose byline prints “Oben JA”